A Call to Action to Track Generic Drug Quality Using Real-World Data and the FDA's Sentinel Initiative.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 32715968.
- Also identified by DOI 10.18553/jmcp.2020.26.8.1050 and PMC identifier 10390989.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The author reports funding from the U.S. Food and Drug Administration to study real-world data approaches to detect generic drug quality issues. There are no further conflicts or disclosures.
Medical subject headings
- Drug Approval
- Drugs, Generic
- Insurance Claim Review
- Pragmatic Clinical Trials as Topic
- United States Food and Drug Administration